Lintuzumab, CAS 166089-32-3

Product Description: Lintuzumab (HUM-195) is an anti-CD33 humanized monoclonal antibody. Lintuzumab reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells. Lintuzumab promotes tumor cell killing through antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP) activities against MDR? and MDR+ AML cell lines and primary AML patient samples. Lintuzumab enhances survival and reduces tumor burden in mice[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Lintuzumab

CAS Number: 166089-32-3

Molecular Weight: N/A

Compound Purity: 98.09

Research Area: Inflammation/Immunology

Solubility: H2O

Target: Others;Radionuclide-Drug Conjugates (RDCs);Transmembrane Glycoprotein

• SKU: MEXHY-P9983-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9983-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated